Sorted By:

Relevance


PhRMA Statement on 2013 Special 301 Report

PhRMA  |  Press Release

The Special 301 process garners high-level attention from our trading partners -- attention that is needed to redress intellectual property violations and market access concerns within individual markets and to send signals to other U.S. trading partners that protecting American intellectual property is important to the U.S. economy.
https://www.phrma.org/press-release/phrma-statement-on-2013-special-301-report

List of 2017 Immuno-Oncology Medicines in Development

PhRMA  |  Report

More than 240 immuno-oncology treatments in development are accelerating progress for patients with cancer.
https://www.phrma.org

More than 430 New Medicines in Development for Top Chronic Diseases Affecting Older Americans

PhRMA  |  Press Release

Washington, D.C. (June 16, 2014) — America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new .phrma.org/sites/default/files/pdf/2014-m...
https://www.phrma.org/press-release/more-than-430-new-medicines-in-development-for-top-chronic-diseases-affecting-older-americans

Nearly 400 Medicines and Vaccines In Development to Fight Infectious Diseases

PhRMA  |  Press Release

Boston, Mass. (Sept. 10, 2010) — Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America’s biopharmaceutical research companies this ...
https://www.phrma.org/press-release/nearly-400-medicines-and-vaccines-in-development-to-fight-infectious-diseases

Nearly 300 Medicines in Development to Meet Unique Needs of Children

PhRMA  |  Press Release

The nearly 300 medicines in development listed in the new report reflect these ongoing efforts.
https://www.phrma.org/press-release/nearly-300-medicines-in-development-to-meet-unique-needs-of-children

PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders

PhRMA  |  Press Release

Washington, D.C. (July 13, 2015) — America’s biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis (MS) and Parkinson’s disease. As highlighted in...
https://www.phrma.org/press-release/phrma-and-epilepsy-foundation-report-more-than-400-medicines-in-development-to-treat-neurological-disorders

No Meaningful Standards to Ensure Disproportionate Share Hospitals Are Providing Care to Low-Income Patients

Chartpack  |  From Our Network

Nonpublic hospitals must meet criteria that show they have been formally delegated governmental powers by a state or local government or have a contract to provide care to low-income or uninsured patients. ...
http://chartpack.phrma.org/programs-chartpack/medicines-in-340b/no-meaningful-standards-to-ensure-disproportionate-share-hospitals-are-providing-care-to-low-income-patients

Medicines in Development for Immuno-Oncology 2017 Report

PhRMA  |  Report

More than 240 immuno-oncology treatments in development are accelerating progress for patients with cancer.
https://www.phrma.org/medicines-in-development-immuno-oncology

PhRMA and Lupus Foundation of America Report More Than 300 Medicines in Development for Autoimmune Diseases

PhRMA  |  Press Release

WASHINGTON, D.C. (September 12, 2016) – A new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) and Lupus Foundation of America highlig...
https://www.phrma.org

Medicines in Development for Mental Illnesses 2017 Report

PhRMA  |  Report

Biopharmaceutical research companies are developing more than 140 medicines for mental illnesses.
https://www.phrma.org/report/medicines-in-development-for-mental-illnesses-2017-report

Together - Depression

PhRMA  |  Video

...
https://www.phrma.org

Medicines in Development for Neurological Disorders 2015 Report

PhRMA  |  Report

Biopharmaceutical researchers are developing more than 400 medicines for a wide range of neurological disorders, including disorders of the brain, spinal cord and nerves.
https://www.phrma.org/report/medicines-in-development-for-neurological-disorders-2015-report

Distribution of Charity Care Among DSH Hospitals With More Than One Contract Phramacy

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/distribution-of-charity-care-among-dsh-hospitals-with-more-than-one-contract-phramacy

Video: PhRMA CEO discusses medicine costs with CNBC's Squawk Box

PhRMA  |  Blog Post

Visit PhRMA.org/LetsTalkCost to learn more.
http://catalyst.phrma.org/video-phrma-ceo-discusses-medicine-costs-with-cnbcs-squawk-box

The Washington Post retracts PhRMA claim in opioid story

PhRMA  |  Blog Post

Earlier this week, The Washington Post falsely claimed that the PhRMA supported the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and spent $40 million advocating for its enactment.
http://catalyst.phrma.org/the-washington-post-retracts-phrma-claim-in-opioid-story

Supporting Global Intellectual Property Priorities

PhRMA  |  Press Release

“PhRMA’s Special 301 submission identifies specific countries that need to improve intellectual property protection and enforcement for pharmaceutical products or that maintain market access barriers which subvert intellectual property protection.
https://www.phrma.org/press-release/phrma-301-submission-supports-global-intellectual-property-priorities

Nearly 1,300 Clinical Trials Conducted in the State Since 1999

PhRMA  |  Press Release

DES MOINES, IA (January 9, 2014) – Working with Iowa research institutions, including the members of the new Iowa Coalition of Clinical Researchers (ICCR), the nation’s biopharmaceutical research companies have conducted 1,287 clinical trials of new medicines in the state since 1...
https://www.phrma.org/press-release/nearly-1-300-clinical-trials-conducted-in-the-state-since-1999

Medicines in Development for Infectious Diseases 2013 Report

PhRMA  |  Report

Throughout history, infectious diseases have taken a devastating toll on the lives and well-being of people around the world. Caused when pathogens such as bacteria or viruses enter a body and multiply, infectious diseases were the leading cause of death in the United States until the 1920s. Toda...
https://www.phrma.org

Excerpts from testimony by PhRMA’s Lori Reilly

PhRMA  |  Blog Post

Market-Based Approaches Are the Best Solution for Addressing Health Care Affordability and Controlling Costs These include encouraging payers to share negotiated savings with patients at the pharmacy counter; reforming outdated regulations hindering the adoption of value based payment arrangements, reforming the 340B drug discount program to better serve the purpose for which it was created; and continuing to modernize the FDA and ensure robust generic and biosimilar competition.
http://catalyst.phrma.org/excerpts-from-testimony-by-phrmas-lori-reilly

PhRMA Urges USTR to Protect American Innovators Abroad

PhRMA  |  Blog Post

Published annually, the Special 301 Report reviews intellectual property protection and enforcement abroad.
http://catalyst.phrma.org/phrma-urges-ustr-to-protect-american-innovators-abroad

Research in Michigan

PhRMA  |  Research In Your Backyard

Today, companies and their local partners are conducting nearly 400 trials of new medicines.
https://www.phrma.org/research-in-your-backyard/research-in-michigan

2017 Research & Hope Awards honor innovators in mental health

PhRMA  |  Blog Post

According to a new report released today, there are more than 140 medicines in development to treat mental illnesses such as anxiety, depression, schizophrenia and more.
http://catalyst.phrma.org/2017-research-hope-awards-honor-innovators-in-mental-health

Medicare Monday: New report highlights progress in fighting cancer with new physician-administered medicines

PhRMA  |  Blog Post

A new report released this month found that there are more than 240 new immuno-oncology treatments in development – treatments designed to enable the patient’s own immune system to fight cancer. 
http://catalyst.phrma.org/medicare-monday-new-report-highlights-progress-in-fighting-cancer-with-new-physician-administered-medicines

Research in Alabama

PhRMA  |  Research In Your Backyard

Of the more than 3,400 clinical trials, 1,514 target the nation’s six most debilitating chronic diseases— asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
https://www.phrma.org/research-in-your-backyard/research-in-alabama

Medicare Part D Savings

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/medicare-part-d-savings

You have reviewed the first 100 results out of 430. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next